Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
26-28 August, 2025
Not Confirmed
Not Confirmed
24-25 July, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Not Confirmed
Not Confirmed
24-27 July, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
26-28 August, 2025
Industry Trade Show
Not Confirmed
24-25 July, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Industry Trade Show
Not Confirmed
24-27 July, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint
23 Jun 2025
// CONTRACTPHARMA
https://www.contractpharma.com/breaking-news/nutriband-kindeva-complete-commercial-scale-up-for-aversa-fentanyl/
12 Feb 2025
// CONTRACTPHARMA
https://www.contractpharma.com/breaking-news/nutriband-and-kindeva-to-co-develop-aversa-fentanyl-abuse-deterrent-patch/
31 Oct 2024
// ACCESSWIRE
https://www.accesswire.com/937286/nutriband-inc-issued-full-patent-from-the-chinese-national-intellectual-property-administrant-for-its-abuse-and-misuse-deterrent-transdermal-system-application
17 Oct 2024
// ACCESSWIRE
https://www.accesswire.com/932563/nutriband-inc-mosquito-repellent-patch-approved-by-ministry-of-health-of-costa-rica
20 Sep 2024
// ACCESSWIRE
https://www.accesswire.com/920557/nutriband-licenses-bitrexr-brand-aversive-agent-for-its-lead-product-aversatm-fentanyl-transdermal-patch
16 Sep 2024
// ACCESSWIRE
https://www.accesswire.com/918230/nutriband-inc-authorizes-1m-share-buyback-program
ABOUT THIS PAGE